Ross, Brian D. http://orcid.org/0000-0003-2695-9140
Jang, Youngsoon
Welton, Amanda
Bonham, Christopher A.
Palagama, Dilrukshika S. W.
Heist, Kevin
Boppisetti, Jagadish
Imaduwage, Kasun P.
Robison, Tanner http://orcid.org/0000-0001-6407-6475
King, Leah R.
Zhang, Edward Z. http://orcid.org/0000-0002-4396-7639
Amirfazli, Cyrus
Luker, Kathryn E.
Lee, Winston Y.
Luker, Gary D. http://orcid.org/0000-0001-6832-2581
Chenevert, Thomas L.
Van Dort, Marcian E. http://orcid.org/0000-0002-4206-6230
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R35CA197701, U24CA237683, R01CA238023, R50CA221807, P30CA046592)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 24 September 2021
Accepted: 19 July 2022
First Online: 17 August 2022
Competing interests
: B.D.R. and M.V.D. are inventors on patents describing the underlying compounds owned by the University of Michigan and may receive royalty payments from the University. Compound patents have been licensed to <i>Lympharma</i>, a company in which B.D.R. has a financial interest. The remaining authors declare no competing interests.